导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -5.10% | 3416/4773 |
| 近一周 | -2.53% | 4001/5465 |
| 近一月 | 0.19% | 653/5421 |
| 近一季 | 1.07% | 776/5231 |
| 近半年 | -8.72% | 3543/4920 |
| 近一年 | -2.39% | 3044/4394 |
| 近两年 | 28.87% | 2328/2954 |
| 近三年 | 20.21% | 1479/2253 |
| 成立以来 | 147.82% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-1.17% 2160/4961 |
-10.96% 4212/5312 |
- - |
- - |
| 2025 | 8.36% 2903/4813 |
-4.90% 3233/3635 |
2.71% 1412/4076 |
7.94% 3427/4524 |
2.77% 855/4813 |
| 2024 | 27.40% 193/3463 |
9.71% 119/2808 |
2.79% 309/3014 |
12.26% 2385/3129 |
0.64% 1187/3463 |
| 2023 | -0.77% 473/2656 |
7.03% 611/2280 |
-0.91% 428/2385 |
0.85% 335/2515 |
-7.23% 2093/2655 |
| 2022 | -10.02% 194/2207 |
-5.65% 197/1919 |
1.58% 1451/2016 |
-9.77% 307/2113 |
4.05% 598/2208 |
| 2021 | 11.18% 406/1822 |
2.02% 232/1255 |
-0.13% 1129/1330 |
8.08% 167/1466 |
0.96% 1032/1822 |
| 2020 | 17.17% 766/1250 |
-10.17% 762/1028 |
2.71% 962/1067 |
16.97% 125/1164 |
8.57% 668/1184 |
| 2019 | 22.29% 643/1092 |
20.21% 612/754 |
-3.43% 396/804 |
-1.51% 660/850 |
6.96% 509/918 |
| 2018 | -22.64% 252/834 |
- - |
- - |
- - |
-10.21% 181/691 |
| 2017 | 16.68% 234/714 |
- - |
- - |
- - |
- - |
| 2016 | -0.95% 115/605 |
- - |
- - |
- - |
- - |
| 2015 | 3.61% 233/575 |
- - |
- - |
- - |
- - |
| 2014 | 67.00% 19/237 |
- - |
- - |
- - |
- - |
| 2013 | -9.61% 148/186 |
- - |
- - |
- - |
- - |
| 2012 | 5.05% 78/140 |
- - |
- - |
- - |
- - |
| 2011 | -22.65% 51/102 |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 万家中证港股通创新药ETF | 1.5896 | 28.31% |
| 景顺长城中证港股通创新药ETF | 1.6507 | 28.23% |
| 港股医疗 | 0.9366 | 28.18% |
| 港股医疗ETF | 1.4282 | 28.15% |
| 港股通医疗ETF工银 | 0.9464 | 28.06% |
| 港股通医疗ETF华宝 | 0.9577 | 27.97% |
| 天弘恒生沪深港创新药精选50ETF发起联接C | 1.2844 | 27.92% |
| 天弘恒生沪深港创新药精选50ETF | 0.8437 | 27.35% |
| 万家中证港股通创新药ETF发起式联接A | 1.3863 | 27.32% |
| 万家中证港股通创新药ETF发起式联接C | 1.3856 | 27.27% |
| 中证南方小康产业指数ETF VS. 长安沪深300非周期A(740101) |